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primary Hyperparathyroidism and Associated Neoplasms
gelos A. Kambouris, MD,* Mohammed R. Ansari, MD,* and Gary B. Talpos, MD*

An

sequential bilateral breast cancers and colon cancer, the last one
16 years prior to parathyroidectomy; and another patient had
undergone surgical treatment of cancer of the larynx and of the
lung, the latter one three years prior to parathyroidectomy. In all
instances, carcinoma had been successfully treated, and detailed investigation failed to reveal metastases. Benign thyroid
nodules were found and excised in two of these patients at parathyroidectomy. Hypercalcemia was corrected in all ten patients
by removal of a single adenoma in seven patients and two or
more hyperplastic glands in the remaining three patients.
Nine patients (8.1%) were found to have concurrent malignant neoplasms at parathyroidectomy (Table 2). One of these
patients (case 1, Table 2), a 68-year-old white woman, had
squamous cell carcinoma of the tongue with neck metastases.
Primary hyperparathyroidism was diagnosed through orderly
workup of her hypercalcemia. Removal of two hyperplastic
parathyroids at thetimeof radical neck dissection corrected her
hypercalcemia. Of the remaining eight patients, five had occult
papillary thyroid carcinomas found and excised at parathyroidectomy. Four of these (cases 3-6, Table 2) were incidental
Materials and Methods
findings in the histological examination of excised thyroid nodThe records of 111 patients who underwent parathyroidectomy
ules. The fifth patient (case 2, Table 2) was found to have an 11
between January 1, 1980, and December 31, 1983, were retromm papillary thyroid cancer in a totally atrophic thyroid gland
spectively reviewed. The series included 85 women (76.5%)
during removal of three parathyroid glands, only one of which
and 26 men ranging in age from 25 to 91 years, with a median
was hyperplastic. Hypercalcemia persisted, and the patient was
age of 57 years. Of the 111 patients, 84 were white and 27 were reoperated on two months later Reexploration of the neck and
black.
mediastinal exploration failed to locate the missing parathyroid.
Operative reports, histopathological reports, and discharge
The patient was hypercalcemic two years later Another patient
summaries were carefully reviewed to ascertain primary diag(case 9, Table 2), the only one with irradiation to the neck for
nosis, associated tumors or tumorous conditions found at ophypertrophic tonsils 24 years previously, underwent total thyeration, and extent of operative procedures performed. In all
roidectomy and subtotal parathyroidectomy for concurrent
instances, information regarding existing or previously treated
papillary thyroid cancer and parathyroid hyperplasia. Hyneoplasms was carefully sought, and the status of such maligpercalcemia persisted but was corrected when additional
nancies was recorded. In addition, information regarding prehyperplastic parathyroid tissue was excised five months later
vious operations in the head and neck area, and exposure to
The remaining two patients (cases 7 and 8, Table 2) had
neck irradiation, was carefully extracted. Postoperative calcium
levels were also reviewed to assess the effectiveness of parathyroidectomy in controlling hypercalcemia.

requent use of automated multichannel analyzers has contributed to the diagnosis of hypercalcemia in large numbers
of patients, many of them completely asymptomatic. While primary hyperparathyroidism has been diagnosed in 0.1% to 0.3%
ofthese patients, malignant neoplasms continue to be the most
frequent cause of hypercalcemia (1,2). This is particulariy tme
inpatients with known and previously treated cancers, where
hypercalcemia is attributed to bone metastases or to humoral
factors secreted by the neoplasms, downplaying the role of
primary hyperparathyroidism as the underlying cause. Such
assumptions may lead to inappropriate workup, to delay in diagnosis, and occasionally to treatment delay in patients with previously treated cancers that are known to have a poor prognosis.
The repetitive encounter of patients with hypercalcemia, either
en-oneously attributed to malignancy or whose parathyroid disease was left untreated because of previously treated cancers,
prompted a review of our experience with parathyroidectomy
over a four-year period and formulates the basis for this report.

F

Results
Ten (9%) of the 111 patients underwent treatment for 13 \ m °"s invasive cancers prior to parathyroidectomy. Table 1 details
histologic types and time of definitive treatment of those carcinomas as well as parathyroid histology on the excised glands.
Significantiy, one patient had undergone successful treatment of
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Table 1
Patient
No.
1

Age/Sex
7 I/F

2
3
4

55/F
67/F
66/M

5

57/F

6

76/F

7
8
9

58/M
25/F
58/F

10

43/F

Previously Treated
Carcinoma
Carcinoma left breast
Carcinoma right breast
Carcinoma right colon
Carcinoma right breast
Carcinoma of colon
Carcinoma of bladder
(cystectomy, ileal loop)
Papillary thyroid
carcinoma
Carcinoma of rectosigmoid
colon (low resection)
Carcinoma of stomach
Carcinoma of colon
Carcinoma of larynx
(laryngectomy);
carcinoma of lung.
resected
Renal adenocarcinoma
(nephrectomy)

Treatment
Year
1962
1966
1966
1979
?
1967

Parathyroid
Diagnosis
Adenoma

Treatment
Year
1982

Additional Findings
and Comments
Hysterectomy 1962
F^otidectomy 1971

Adenoma
Adenoma
Hyperplasia, 2 glands

1982
1983
1980

Multinodular goiter

1979

Adenoma

1980

Hashimoto's thyroiditis

1967
1976
1980

Adenoma
Adenoma
Adenoma

1981
1981
1981

Sarcoidosis

1975

Nodular hyperplasia.
2 glands

1981

Hyperplasia,
3 '/2 glands

1980

1978
1977

clinically recognized and appropriately treated papillary cancers
at parathyroidectomy. Excluding the patient with oral cancer, associated nonmalignant thyroid nodules were excised infiveof
these eight patients and in fact led to the diagnosis of all thyroid
cancers.
Eight patients (7.2%) had nonneoplastic thyroid nodules
of significance at parathyroidectomy (cases 1 and 2, Table 1,

and cases 1-6, Table 2). Seven of the excised nodules were ofthe
colloid variety, and one represented Hashimoto's thyroiditis.
Parathyroidectomy was successful in seven patients, but misinterpretation of a colloid nodule at surgery accounted for the
failure to identify parathyroid pathology in one patient. She was
subsequently reoperated on elsewhere, and her hypercalcemia
was corrected. Thus, nonneoplastic thyroid nodules alone (eight

Table 2
Hyperparathyroidism and Concurrent Carcinoma
Patient
No.

Age/Sex
68/F

Parathyroid
Diagnosis
Hyperplasia.
2 glands

Treatment
Year
1982

Concurrent
Carcinoma
Squamous cell
carcinoma of
tongue, with
neck metastases
Papillary thyroid
carcinoma

57/F

Hyperplasia

1982

54/F

Adenoma

1982

Papillary thyroid
carcinoma (11 mm)

52/F

Hyperplasia

1983

66/F

Adenoma

1980

53/F

Adenoma

1980

61/F

Adenoma

1981

40/F

Adenoma

1981

33/F

Hyperplasia

1982

Papillary thyroid
carcinoma (4 mm)
Occult papillary
thyroid
carcinoma
Sclerosing
papillary thyroid
carcinoma
Papillary thyroid
carcinoma
Papillary thyroid
carcinoma
Papillary thyroid
carcinoma
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Other Concurrent
Tumors
Colloid nodular
goiter
Colloid nodules.
Hashimoto's
thyroiditis

Attophic thyroid
gland

Treatment and
Comments
Partial thyroidectomy;
subtotal parathyroidectomy.
Glossectomy and radical
neck dissection, 1982.
Total thyroidectomy and
renioval of three
parathyroid glands
9/82. Mediastinal
exploration and neck
reexploration 11/82.
Continues to have
hypercalcemia, 1984.
Total thyroidectomy,
1982. Hysterectomy
for leiomyoma of
uterus, 1955.
Partial thyroidectomy

Multinodular
goiter

Partial thyroidectomy

Multinodular
goiter

Partial thyroidectomy

Colloid nodule

Subtotal thyroidectomy
Subtotal thyroidectomy
Tonsil irradiation 1959.
Total thyroidectomy and
subtotal parathyroidectomy
10/82; persistent hypercalcemia. Additional remow
of parathyroid tissue 3/83
corrected hypercalcemia;—
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Instances), with concurrent thyroid cancers (five instances), or
in patients treated for carcinomas prior to parathyroidectomy
/[vvo cases) were present in 15 (13.5%) of the 111 patients in this
jgries (Table 3).
Three patients had benign thyroid neoplasms resected at
parathyroidectomy. Two of these were benign follicular adenomas; the third was a benign Hurthle cell tumor Hashimoto's
thyroiditis was also present in this last patient. In addition, a follicular adenoma had been resected seven years before parathyroidectomy in one patient. Thus, concurrent or previously
treated benign thyroid neoplasms were found in four patients in
this series.
Four additional patients were known to have multiple endocrine neoplasia (MEN) syndromes, and their neoplasms were
not included in this analysis. In addition, three of the patients
had undergone surgical treatment for benign neoplasms of remote organs years prior to parathyroidectomy (parotid gland,
ovaries, and utems).
In summary, 38 (34.2%) of 111 patients had various tumors or
tumorous conditions either previously treated or concurrently
managed at the time of parathyroid resection. Ten (9%) had been
successfully treated for invasive cancers. Nine (8.1%) had concurrent cancers, eight of them involving the thyroid gland, four
had neoplasms related to MEN syndromes, and four had benign
thyroid neoplasms. Nonneoplastic nodules, either alone or in
conjunction with concurrent or previously treated cancers, were
found in 15 (13.5%) of the patients. Thesefindingsand the details of the types of the previously treated carcinomas are summarized in Table 3.

Table 3
Neoplasms and Ibmorous Conditions Documented in 111
Patients Operated on for Hyperparathyroidism
Types of Tumors

No. of ftaients

Previously treated carcinomas
Nonthyroid carcinomas 12
Thyroid carcinomas 1
Concurrent nonthyroid carcinomas
Concurrent thyroid carcinomas
Benign thyroid adenoma
Follicular adenoma 3
Hurthle cell tumor 1
MEN-related neoplasms
Benign tumors, remote organs
Benign thyroid nodules, biopsied or excised

K)

4
3*

.38
Total
*One patient with concurrent thyroid cancer had hysterectomy for leiomyoma of the
uterus.

removed, while small or insignificant nodular disease or thyroiditis may not be biopsied or resected. While the frequency of
nodular thyroid disease in our patients falls in the range of that
reported in the literature, only one patient in the entire group had
been exposed to neck irradiation 24 years before undergoing
total thyroidectomy for papillary thyroid cancer and parathyroidectomy for hyperplasia. Irradiation to the neck cannot be
considered a causative factor in the development of nodular thyroid disease, nonmedullary thyroid cancers, or primary hyperparathyroidism in this series. Since Rao et al (8) reported in
1980 a 17% incidence of childhood irradiation among 130 patients with hyperparathyroidism from our institution and a 5%
prevalence of hyperparathyroidism in irradiated patients (30
times that found in the general population), the issue of iiradiaDiscussion
tion exposure needs to be further investigated. Failure of our paThe association of primary hyperparathyroidism with nodular
tients to recall such information, or failure to obtain and record
thyroid disease and also with nonmedullary thyroid carcinoma
such infonnation, may account for the difference.
has been extensively reported in the past 30 years. Comprehensive reports by Prinz et al (3), Nishiyama et al (4), Linos et al (5),
The association of nonthyroid cancers and hyperparaGranberg et al (6), and Hedman and Tisell (7) summarize availthyroidism was emphasized by Katz et al (9) in a 1970 report of
able information.
six patients with primary hyperparathyroidism and breast canThese reports emphasize that 1) nodular thyroid disease is
cer Subsequent to that report, Kaplan et al (10) reported on an
found in 20% to 50% of patients undergoing parathyroidectomy; autopsy study of 200 cases; 42% of patients with parathyroid
2) nonmedullary thyroid carcinoma of the occult as well as of
adenomas found at autopsy and 16% of those with surgically
the clinically significant variety occurs in 1.5% to 24.5% of the
confirmed adenomas had malignancies of other organs. In 1973
patients; 3) this association is more obvious in patients with
Fan- et al (11) reported that 34 of 100 patients undergoing treatprior exposure to neck irradiation, especially for papillary thyment for primary hyperparathyroidism at Memorial Hospital,
roid cancers; and 4) many patients with primary hyperparaNY, had other cancers, antecedent, concurrent, or subsequent
thyroidism, when carefully questioned, will confirm irradiato parathyroidectomy. In 1974 Samaan et al (12) reemphasized
tion exposure at some remote point in the past.
this association in reporting on 23 patients who underwent
preoperative
localization and surgical treatment of hyperIn our series, 15 patients (13.5%) had thyroid nodules of nonparathyroidism.
Ten of these 23 patients (43.4%) had other tuneoplastic nature excised at parathyroidectomy, and another ten
mors, nine of them carcinomas. Two of the nine carcinomas
patients (9%), excluding the four MEN-related cancers, had
were in the thyroid, but seven were in other organs, including
nonmedullary thyroid cancers excised. Two additional patients
two intestinal carcinoids and one islet cell tumor of the panhad been previously treated for nonmedullary thyroid cancers,
creas. In our series ten patients (9%) had been treated for 13 difand one had a follicular adenoma resected seven years before
ferent carcinomas prior to parathyroidectomy (Tables 1 and 3).
parathyroidectomy. Thus, 25% of the patients in this series had
All cancers were inactive at the time of workup of the hypernodular thyroid disease, the majority resected at parathyroidcalcemia, and primary hyperparathyroidism was confirmed in
ectomy. This association may in fact be lower than its actual ocall instances. Breast, colon, and urinary tract cancers were the
'•''rrence, since only significant thyroid nodules are likely to be
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most frequent types, but the numbers are too small to be significant. Diagnosis of primary hyperparathyroidism in these patients was established through an orderly process of mling out
active cancers or bone metastases by multiple documentations
or elevated semm calcium levels, elevated immunoreactive parathormone and nephrogenous cyclic AMP, and other appropriate
studies. Such a diagnostic process, as emphasized by Pumell et
al (2), Skrabanek et al (13), and Drezner and Lebovitz (14), facilitates the diagnosis of primary hyperparathyroidism and its
differentiation from pseudohyperparathyroidism or from hypercalcemia of skeletal metastases. Despite the definitive exclusion
of active cancers, parathyroidectomy was occasionally delayed
for reasons difficult to pinpoint. Eventually, however, primary
hyperparathyroidism was surgically conected in all ten patients
with a history of previously treated cancer This experience underscores the importance of appropriate workup of hypercalcemia in patients with a history of or concunent invasive carcinomas and de-emphasizes the theoretical fear of metastases in
that particular subgroup of hypercalcemic patients.

Conclusions
In our review of 111 patients undergoing parathyroidectomy
over a four-year period, 38 patients (34.2%) had associated or
previously treated tumors and tumorous conditions of the thyroid or of other organs. Significantly, nine patients had concunent carcinomas, eight of them of the thyroid gland, and ten
patients had undergone successful treatment for 13 various
carcinomas before parathyroidectomy.
The frequent concunence of thyroid nodules and primary
hyperparathyroidism mandates extremely careful assessment
and appropriate management of all thyroid masses at parathyroidectomy. Hypercalcemia in patients with previously
treated cancers should be independently evaluated, and primary
hyperparathyroidism should be excluded. In absence of bone
metastases, hypercalcemia due to parathormone-like activity is
rare. Therefore, biochemical evaluation of such patients should

210 Henry Ford Hosp Med J—Vol 35, No 4, 1987

include multiple calcium and phosphoms determinations, parathormone determinations, and nephrogenous cyclic AMP measurements to facilitate diagnosis. If the diagnosis of primary
hyperparathyroidism is established, timely parathyroidectomy
should be considered depending on risk factors and other
clinical parameters.
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